Keywords: BMI; body mass index; MHO; metabolically healthy obese; NAFLD; non-alcoholic liver disease; MUHO; metabolically unhealthy obese; RCT; randomized clinical trial; APRI; AST-to-platelet ratio index; HOMA-IR; homoeostasis model assessment for insulin resistan